Overview

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Status:
Terminated

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of pediatric patients with autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS).

Phase:

Phase 2

Details

Lead Sponsor:

Forest Laboratories

Treatments:

Memantine